Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions

Breast Cancer

Interventions

DRUG

Sodium-glucose transport-2 (SGLT-2) inhibitors

Dapagliflozin 10mg in addition to standard clinical care

OTHER

Standard medical treatment

Standard clinical care

Trial Locations (1)

University of Aberdeen, Aberdeen

All Listed Sponsors

collaborator

NHS Grampian

OTHER_GOV

lead

University of Aberdeen

OTHER